cbd dementia benefits

CBD Dementia Effects

This study summary provides fact-based answers about CBD benefits for brain aging and dementia.

  • learn why CBD is a promising treatment for dementia
  • know exactly how CBD helps protect the brain from aging and dementia
  • discover the oral CBD dosages being tested and possible adverse effects
  • find out how this powerful nonintoxicating compound can benefit you

If you don’t find an answer in this guide to a question you have, leave us a comment below. We’ll search the published studies to see if an answer exists and get back to you.

Let’s get started.

 

2020 Study: CBD dementia benefits are being investigated in new double-blind trial. #cbd #dementia tell a friend

 

nih medical study

Published February 2019

 

 

 

 

Our summary

  • This study will test the safety of a cannabis-based oil with a THC:CBD ratio of 3:2 (3 parts THC to 2 parts CBD).
  • The study will test CBD benefits for dementia by assessing effects on dementia behavior symptoms, quality of life and pain relief (1).

cannabidiol dementia benefits

 

Method

  • 18 week, randomized, double-blind crossover trial
  • 2-week eligibility period
  • two 6-week treatment cycles
  • two 2-week washout periods (2)

 

nih medical study

 

 

Participants

  • 50 participants with dementia
  • currently living in a residential care facility (3)

 

nih medical study

 

Evaluation

Data will be collected on 7 occasions for the following assessments:

nih medical study  

 

 

 

Do you struggle with chronic pain or know someone who does? Patients over 50 with chronic pain symptoms have quality sleep and wake up less during the night.  See the full study here.

 

 

 

Video: Care for the elderly with cannabinoids

 

 

Download The Study

 

 

Keywords: PainBehavioural and neuropsychiatric symptoms of dementia (BPSD); Crossover trial; Dementia; Medicinal cannabis; Quality of life

 

 

 References

Timler A, Bulsara C, Bulsara M, Vickery A, Smith J, Codde J. Use of cannabinoid-based medicine among older residential care recipients diagnosed with dementia: study protocol for a double-blind randomised crossover trial. Trials. 2020;21(1):188. Published 2020 Feb 14. doi:10.1186/s13063-020-4085-x

Study Authors

Timler A

Institute for Health Research, University of Notre Dame Australia

Bulsara C

Institute for Health Research, University of Notre Dame Australia

Bulsara M

Institute for Health Research, University of Notre Dame Australia

Vickery A

Emerald Clinics, Perth

Smith J

Institute for Health Research, University of Notre Dame Australia

Codde J

 Institute for Health Research, University of Notre Dame Australia

Pin It on Pinterest

Share This